Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

NCT01478321 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Stopped Slow accrual to some cohorts

Conditions

Adult Anaplastic Astrocytoma
Adult Anaplastic Ependymoma
Adult Anaplastic Oligodendroglioma
Adult Giant Cell Glioblastoma
Adult Glioblastoma

Interventions

DRUG: Temozolomide
RADIATION: hypofractionated radiation therapy
BIOLOGICAL: bevacizumab
OTHER: questionnaire administration

Sponsor

Northwestern University